This document provides guidance on vaccine dosages, administration routes, injection sites, and needle sizes. It lists various vaccines including their doses, whether they are given intramuscularly, subcutaneously, or intranasally, and recommendations for injection site and needle length based on a person's age and weight. Proper administration technique and adhering to recommendations can help ensure vaccines are safely and effectively administered.
This document provides guidance on vaccine dosages, administration routes, injection sites, and needle sizes. It lists various vaccines including their doses, whether they are given intramuscularly, subcutaneously, or intranasally, and recommendations for injection site and needle length based on a person's age and weight. Proper administration technique and adhering to recommendations can help ensure vaccines are safely and effectively administered.
This document provides guidance on vaccine dosages, administration routes, injection sites, and needle sizes. It lists various vaccines including their doses, whether they are given intramuscularly, subcutaneously, or intranasally, and recommendations for injection site and needle length based on a person's age and weight. Proper administration technique and adhering to recommendations can help ensure vaccines are safely and effectively administered.
This document provides guidance on vaccine dosages, administration routes, injection sites, and needle sizes. It lists various vaccines including their doses, whether they are given intramuscularly, subcutaneously, or intranasally, and recommendations for injection site and needle length based on a person's age and weight. Proper administration technique and adhering to recommendations can help ensure vaccines are safely and effectively administered.
Vaccine Dose Route Injection Site and Needle Size Diphtheria, Tetanus, Pertussis Subcutaneous (Subcut) injection 0.5 mL. . IM .. (DTaP, DT, Tdap, Td) Use a 23–25 gauge needle. Choose the injection site that is appropriate to Haemophilus influenzae type b (Hib) 0.5 mL IM the person’s age and body mass. ≤18 yrs: 0.5 mL age Needle injection site Hepatitis A (HepA) IM length ≥19 yrs: 1.0 mL Fatty tissue over anterolateral Engerix-B; Recombivax HB Infants (1–12 mos) ⅝" thigh muscle Hepatitis B (HepB) ≤19 yrs: 0.5 mL Persons 11–15 yrs may be given Recombivax HB (Merck) >20 yrs: 1.0 mL IM Fatty tissue over anterolateral 1.0 mL adult formulation on a 2-dose schedule. Children 12 mos or older, Heplisav-B ⅝" thigh muscle or fatty tissue ≥18 yrs: 0.5 mL adolescents, and adults over triceps Human papillomavirus (HPV) 0.5 mL IM Intramuscular (IM) injection 0.2 mL (0.1 mL in Intranasal Use a 22–25 gauge needle. Choose the injection site and needle length that Influenza, live attenuated (LAIV) each nostril) spray is appropriate to the person’s age and body mass. Afluria: 0.25 mL needle age length injection site Influenza, inactivated (IIV); for ages Fluzone: 0.25 or 0.5 mL IM 6–35 months Newborns (1st 28 days) ⅝"* Anterolateral thigh muscle FluLaval; Fluarix: 0.5 mL Infants (1–12 mos) 1" Anterolateral thigh muscle Influenza, inactivated (IIV), for ages 3 1–1¼" Anterolateral thigh muscle** years & older; recombinant (RIV), for 0.5 mL IM Toddlers (1–2 years) ages 18 years and older ⅝–1"* Deltoid muscle of arm
Measles, Mumps, Rubella (MMR) 0.5 mL Subcut Children ⅝–1"* Deltoid muscle of arm** (3–10 years) 1–1¼" Anterolateral thigh muscle Meningococcal serogroups A, C, W, Y 0.5 mL IM (MenACWY) ⅝–1"* Deltoid muscle of arm** Adolescents and teens Meningococcal serogroup B (MenB) 0.5 mL IM (11–18 years) 1–1½" Anterolateral thigh muscle Pneumococcal conjugate (PCV) 0.5 mL IM Adults 19 years or older IM or Female or male <130 lbs ⅝–1"* Deltoid muscle of arm Pneumococcal polysaccharide (PPSV) 0.5 mL Subcut Female or male 130–152 lbs 1" Deltoid muscle of arm IM or Polio, inactivated (IPV) 0.5 mL Female 153–200 lbs Subcut 1–1½" Deltoid muscle of arm Male 153–260 lbs Rotarix: 1.0 mL Rotavirus (RV) Oral Female 200+ lbs Rotateq: 2.0 mL 1½" Deltoid muscle of arm Male 260+ lbs Varicella (VAR) 0.5 mL Subcut Shingrix: 0.5* mL IM * A 5/8" needle may be used in newborns, preterm note: Always refer to the package insert Zoster (Zos) infants, and patients weighing less than 130 lbs included with each biologic for complete Zostavax: 0.65 mL Subcut (<60 kg) for IM injection in the deltoid muscle vaccine administration information. CDC’s Combination Vaccines only if the skin stretched tight, the subcutaneous Advisory Committee on Immunization tissue is not bunched, and the injection is made DTaP-HepB-IPV (Pediarix) at a 90-degree angle to the skin. Practices (ACIP) recommendations for the DTaP-IPV/Hib (Pentacel) 0.5 mL IM ** Preferred site particular vaccine should be reviewed as DTaP-IPV (Kinrix; Quadracel) well. Access the ACIP recommendations at www.immunize.org/acip. MMRV (ProQuad) ≤12 yrs: 0.5 mL Subcut HepA-HepB (Twinrix) ≥18 yrs: 1.0 mL IM * The vial might contain more than 0.5 mL. Do not administer more than 0.5 mL.
